V
GSK icon

ViaWealth’s GSK GSK Stock Holding History

ViaWealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$372K Sell
6,735
-1
-0% -$54 0.21% 121
2025
Q4 		$330K Sell
6,736
-836
-11% -$39K 0.19% 119
2025
Q3 		$327K Sell
7,572
-19
-0.3% -$742 0.18% 130
2025
Q2 		$291K Sell
7,591
-2,035
-21% -$77.8K 0.17% 133
2025
Q1 		$373K Sell
9,626
-4,864
-34% -$178K 0.23% 117
2024
Q4 		$490K Sell
14,490
-4,357
-23% -$157K 0.3% 97
2024
Q3 		$770K Sell
18,847
-2,394
-11% -$97.9K 0.45% 72
2024
Q2 		$818K Sell
21,241
-994
-4% -$41.8K 0.51% 64
2024
Q1 		$953K Sell
22,235
-645
-3% -$26.6K 0.6% 51
2023
Q4 		$848K Sell
22,880
-8,100
-26% -$291K 0.58% 51
2023
Q3 		$1.12M Buy
30,980
+1,665
+6% +$59.1K 0.82% 30
2023
Q2 		$1.04M Buy
29,315
+1,725
+6% +$61.9K 0.78% 32
2023
Q1 		$982K Buy
27,590
+9,475
+52% +$331K 0.78% 33
2022
Q4 		$626K Buy
+18,115
New +$603K 0.51% 69

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ViaWealth's GSK Position: Q1 2026 in Review

ViaWealth reduced its GSK (GSK) stake by 0.01% in Q1 2026, selling an estimated $54 and leaving 6,735 shares worth $372K. The position accounts for 0.21% of the portfolio, ranked #121.

ViaWealth first reported a position in GSK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.12M in Q3 2023. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • ViaWealth held 6,735 shares of GSK worth $372K as of Q1 2026.
  • ViaWealth sold 1 GSK share in Q1 2026, an estimated $54.
  • GSK made up 0.21% of ViaWealth's portfolio in Q1 2026, its #121 holding.
  • ViaWealth first reported a position in GSK in Q4 2022 and has held it in 14 quarters since.
  • ViaWealth's GSK position peaked at $1.12M in Q3 2023.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on ViaWealth's 13F filing for Q1 2026, filed 11 May 2026.